Acurx announces additional ibezapolstat ph2b results in cdi as well as anthrax (b. anthracis) susceptibility to acx-375 analogues

New analyses extend data on beneficial effects of ibezapolstat on the gut microbiome confirmed ibezapolstat's favorable pharmacokinetics showing low systemic exposure and high colonic concentrations selected acx-375 analogues demonstrated in vitro activity against anthrax (b. anthracis), a bioterrorism category a pathogen, including activity against ciprofloxacin resistant anthrax.
ACXP Ratings Summary
ACXP Quant Ranking